64 citations
Counting papers with at most 25 authors, so collaboration author lists do not stand in for the people here.
- Novartis (Switzerland)CH6 papers
- Medical University of ViennaAT3 papers
- Statistics AustriaAT3 papers
- Novartis (China)CN2 papers
- University Hospital MagdeburgDE2 papers
- AstraZeneca (Sweden)SE1 paper
- Berry & Associates (United States)US1 paper
- Berry Consultants, LLC (United States)US1 paper
- Charité - Universitätsmedizin BerlinDE1 paper
- Constellium (United Kingdom)GB1 paper
- Franklin UniversityUS1 paper
- Institute of Neuroimmunology and Multiple SclerosisDE1 paper
3 papers · 1 filter
Inverse Probability Weighting for Recurrent Event Models
Jiren Sun, Tobias Mutze, Richard Cook +1
Recurrent events are common and important clinical trial endpoints in many disease areas, e.g., cardiovascular hospitalizations in heart failure, relapses in multiple sclerosis, or…
Randomization-based Inference for MCP-Mod
Lukas Pin, Oleksandr Sverdlov, Frank Bretz +1
Dose selection is critical in pharmaceutical drug development, as it directly impacts therapeutic efficacy and patient safety of a drug. The Generalized Multiple Comparison Procedu…
On model-based time trend adjustments in platform trials with non-concurrent controls
Marta Bofill Roig, Pavla Krotka, Carl-Fredrik Burman +9
Platform trials can evaluate the efficacy of several treatments compared to a control. The number of treatments is not fixed, as arms may be added or removed as the trial progresse…